Erasca Falls Short of Q3 2026 Estimates
Revenue of $1.4M and adjusted EPS of -$0.15 vs. -$0.13.
Erasca (ERAS) fell short of estimates for the third quarter of 2026. Revenue was $1.4 million, and adjusted EPS was -$0.15, down 36% from a year earlier, below the -$0.13 estimate.
Shares were unchanged in after-hours trading as of 4:15 p.m. ET, to $15.78 from a $15.78 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | -$0.13 | -$0.15 | Miss by 15% |
By our calculation, adjusted EPS was $0.02 below it.
GAAP results
- GAAP EPS. GAAP diluted EPS was -$0.13, against -$0.11 a year earlier.
- Net loss. The company reported a net loss of $51.3 million on a GAAP basis, compared with a net loss of $30.6 million a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
What to watch
- Next-quarter estimates. Consensus calls for EPS of -$0.13 and revenue of $0 next quarter, based on 6 analysts.
- Next report. Erasca is next expected to report on March 25, 2027.
- Estimate record. Whether Erasca returns to beating EPS estimates, which it did in 3 of its last 8 reports.
- Related coverage. See our reports on Nektar Therapeutics, QXO, Jefferson Capital and Flowers Foods.
Sources: Results are from Erasca's Nov. 12, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Erasca's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Nektar Therapeutics Q3 2026 EPS Tops Estimates at -$1.63, but Revenue Misses at $9.4M
EarningsQXO Tops Q3 2026 Estimates as Revenue Rises 79% to $4.89B
EarningsJefferson Capital Beats Q3 2026 Estimates as Revenue Rises 23% to $185.5M
EarningsFlowers Foods Misses Fiscal Q3 2026 Estimates as Revenue Falls 4.7% to $1.17B
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
